ClinicalTrials.gg
Not yet recruitingNCT06527261eCARE4StrokeUpdated Jul 30, 2024

Electronic Capturing of Activities During REhabilitation for Upper Limb After Stroke

An observational study in Stroke, sponsored by University of Melbourne. Not yet recruiting at 1 site in Australia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-30.

Sponsored by University of Melbourne · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
146
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 122 studies in Stroke with a site in Australia — 22 open to participants now, 29 under way, 11 of them phase 3. Stroke · Australia.

Planned enrollment
11th of 13
146 · median 626
Started
2024
with 7 others
Observational
13 of 122
3 open now
Primary completion
2026-12
later than 9 of 28 live
Registered
113th of 122
by date
Lead sponsor
5 of 122
University of Melbourne

Among the 122 studies in Stroke with a site in Australia, this one is the 11th largest by planned enrollment of the 13 observational ones that give a count, is one of 8 that started in 2024, is one of 13 observational ones, reaches primary completion later than 9 of the 28 other live ones, and was the 113th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

22 of the 122 studies in Stroke with a site in Australia are open now. Recruiting first, the newest first:

17 more — sign in →

All 22 open studies →

A study can be open while its sites in Australia have not opened yet or have stopped. Only those recruiting at a site in Australia →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 122 studies in Stroke with a site in Australia, or all of them as a file.
02

Study summary

This is a prospective cohort study to determine the feasibility of accurate, complete, and timely real-time electronic capturing of upper limb motor intervention sessions during usual care. In clinical trials accurate reporting of usual care for people with stroke is scarce, thus understanding the control group compared to the experimental group is poor. The unit of measure in this study is therapy sessions, where a clinician is providing usual care to a patient.

The observed sessions will occur in two Austin Health settings: Acute at Austin Hospital; subacute, across Royal Talbot Rehabilitation Centre or the Heidelberg Repatriation Hospital. For each session, patient characteristics, dose and content of upper limb interventions will be electronically captured in REDCap. Additionally, the sessions will be video recorded to allow a second rater to assess feasibility. The secondary aim is to determine if there is an association between the dose and content of upper limb intervention sessions and the contextual factors of stroke patients. Two participant groups will be recruited: Stroke patients and Clinicians (Occupational Therapists and Allied Health Assistants).

Read the detailed description

This is a prospective observational cohort study to determine the feasibility of accurate, complete, and timely real-time electronic capturing of upper limb motor intervention sessions during usual care.

In clinical trials accurate reporting of usual care for people with stroke is scarce, thus understanding the control group compared to the experimental group is poor.

The unit of measure is the therapy sessions, where a clinician is providing usual care to a patient. The observed sessions will occur across two Austin Health settings. Setting A: Acute at Austin Hospital, and Setting B: Subacute at Royal Talbot Rehabilitation Centre or the Heidelberg Repatriation Hospital.

For each session, patient characteristics, the multiple dimensions of dose, and the content of usual care motor upper limb interventions will be electronically captured in REDCap. The observed sessions will be video recorded and a second rater will review the session for dose data accuracy. Secondary to determining feasibility, the dose and content data from observed sessions will be analysed to investigate the association of context factors such as setting and upper limb impairment severity.

As such, this study aims to answer the following research questions:

  • Is it feasible for clinicians to electronically capture accurate, complete, and timely upper limb motor intervention session dose during usual care of stroke patients?
  • Is there an association between dose and content of upper limb intervention sessions and the contextual factors of stroke patients?
03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Usual care
  • Upper extremity
  • Dose
  • Rehabilitation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Group 1: Stroke patients These participants will be selected from inpatients within the tertiary health service of Austin Health in Melbourne, Victoria, Australia. They may be located at the acute setting: Austin hospital, Or subacute setting: Heidelberg repatriation hospital or Royal Talbot rehabilitation Centre.

Group 2: Clinicians Clinicians will be invited to participate if they are an Occupational Therapist or allied health assistant working at Austin health with the stroke patient population.

Eligibility criteria

Group 1: Stroke patients

Inclusion Criteria:

  • Adults (≥18 years) with a new, first or consecutive stroke, confirmed on CT or MRI.
  • Motor upper limb impairment defined by a Shoulder Abduction and Finger Extension (SAFE) score of 0 through 9.
  • Able to consent for themselves.
  • Likely to receive at least one upper limb intervention session as determined by the treating clinical team.

Exclusion Criteria:

  • Existing co-morbidities that limit upper limb function and usual care treatment provided as determined by the treating clinical team e.g., neural or orthopeadic
  • Receiving palliative care or have a limited
  • Deemed unable or unnecessary to participate in upper limb intervention by the treating clinical team
  • Treating Occupational Therapist and local allied health assistant declined to participate in the research preventing recording of usual care data
  • Unable to follow basic instructions in English

Group 2: Clinicians

Inclusion criteria

  • Occupational therapist or allied health assistant working with the stroke population in an acute or subacute settings within Austin Health.
  • At least four months of clinical experience

Exclusion criteria:

  • Clinicians expected to move into another clinical area within one month.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
146 participants (estimated)
Target follow-up
4 Months
Patient registry
Yes

Groups and cohorts

  • Acute Sessions

    Observed sessions for patients who are in the acute inpatient setting. Each session will include a patient and a clinician

    Other: Real-time electronic data input into REDCap

  • Subacute Sessions

    Observed sessions for patients who are in the subacute inpatient setting. Each session will include a patient and a clinician

    Other: Real-time electronic data input into REDCap

Interventions

  • OtherReal-time electronic data input into REDCap

    During usual care sessions, clinicians will real-time capture information about the intervention session into REDCap. This information is related to the multi-dimensional dose articulation framework e.g., content of the session and difficulty of the task, session length, episode length, and number of repetitions. The usual care motor upper limb intervention the patient receives is determined by the clinician providing the care. The therapy may include but is not limited to strength training, task specific retraining, constraint induced movement therapy, mirror box, and electrical stimulation.

06

What researchers measure

Primary outcomes

  1. Feasibility of real-time electronic data input of usual care session dose

    A single binary composite primary outcome, where feasibility is defined by 90% of sessions achieving ALL of: 1. Binary outcome of Accuracy: ≤10% difference in dose between electronic data and second-rater data from a video recording of the session as defined by the decision algorithm. 2. Binary outcome of Completeness: ≥90% of the electronic data completed by clinicians as defined by the decision algorithm. 3. Binary outcome of Timeliness: ≤10% of session time is spent completing the electronic record or rated non-burdensome by the clinician as defined by the decision algorithm.

    Time frame: Each feasibility session will take up to one hour.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2024; primary completion for Dec 2026, 29 months later.

Of 838 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 29 months is below that.

Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 11, 2024
First posted
Jul 30, 2024
StartEst.
Jul 2024
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Jul 30, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06527261
Lead sponsor
University of Melbourne
Responsible party
Sponsor
First posted
Jul 30, 2024
Start date
Jul 2024 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jul 30, 2024

Study contacts

Kate Hayward, PhD
Contact
kate.hayward@unimelb.edu.au
+61 03 9035 5511
Sarah P Newton, BOccTh(Hons)
Contact
spnewton@student.unimelb.edu.au
+61 03 94965105
Kate Hayward
principal investigator · University of Melbourne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion